Company news
Medigen Vaccine Biologics Corp. (TPEX:6547) news
Medigen Vaccine Biologics Corp. news releases on 6ix. Latest, Mar 18, 2026: MVC's ENVACGEN® is Granted First Enterovirus A71 Vaccine Marketing Authorization…
Press releases & updates
MVC's ENVACGEN® is Granted First Enterovirus A71 Vaccine Marketing Authorization in Vietnam; Joins Forces with Substipharm Biologics to Expand Southeast Asian Market
March 17, 2026
Medigen Vaccine Biologics : Announcement of the company's resolutions on the stock dividend ex-rights base date
July 14, 2022
Medigen Vaccine Biologics : Announcement of the Company's full receipt of cash capital increase in 2022 and the reference date of capital increase
July 1, 2022
Medigen Vaccine Biologics : Subscription rights to the cash issue forfeited by directors of the Company reaching 50% and subscription being made available to specific persons
June 10, 2022
Medigen Vaccine Biologics : Additional update on clinical development on MVC COVID-19 vaccine in the WHO COVID-19 Solidarity Trial Vaccines (Supplementary Announcement)
June 8, 2022
Medigen Vaccine Biologics : The manufacturing facility of MVC EV71 Vaccine obtained PIC/S GMP certificate from the Ministry of Health and Welfare (MOHW)
June 7, 2022
Medigen Vaccine Biologics : MVC file provisional approval application of COVID-19 Vaccine to Therapeutic Goods Administration
June 6, 2022
Medigen Vaccine Biologics : Announcement the institution designated to collect and deposit for 1st domestic unsecured convertible corporate bonds
April 22, 2022
Medigen Vaccine Biologics : Announcement of the company's cash capital increase subscription date and other related matters (supplemental issue price and banks information)
April 21, 2022
Medigen Vaccine Biologics : Announcement of the company's cash capital increase subscription date and other related matters
April 13, 2022
Medigen Vaccine Biologics : Resolution by the board of directors to distribute dividends
April 6, 2022
Medigen Vaccine Biologics : Resolution to issue new shares for capital increase through profits by Board of Directors
March 1, 2022
Medigen Vaccine Biologics : Board of directors has resolved to issue 1st of unsecured convertible corporate bonds
March 1, 2022
Medigen Vaccine Biologics : Announcement of the company's board of directors resolution of cash capital increase issue of new shares
March 1, 2022
Medigen Vaccine Biologics : Announcement of the board of directors'resolution the date of the shareholders' meeting
March 1, 2022
Medigen Vaccine Biologics : Paraguay approves the Emergency Use Authorization (EUA) of MVC COVID-19 Vaccine
February 14, 2022
Medigen Vaccine Biologics : The interim analysis results of MVC COVID-19 Vaccine phase 3 clinical trial in Paraguay meet the criteria of superiority
February 14, 2022